Optimization and Characterization of Sodium Alginate Beads Providing Extended Release for Antidiabetic Drugs

The current research is aimed at investigating the relationship between the formulation components and conditions in the case of a binary drug delivery system, where antidiabetic drugs are co-formulated into polymeric micelles embedded in sodium alginate. Compared to chemical modifications of polymers with alginate, our development provides a simpler and scalable formulation process. Our results prove that a multi-level factorial design-based approach can ensure the development of a value-added polymeric micelle formulation with an average micelle size of 123.6 +/- 3.1 nm and a monodisperse size distribution, showing a polydispersity index value of 0.215 +/- 0.021. The proper nanoparticles were co-formulated with sodium alginate as a biologically decomposing and safe-to-administer biopolymer. The Box-Behnken factorial design ensured proper design space development, where the optimal sodium alginate bead formulation had a uniform, extended-release drug release mechanism similar to commercially available tablet preparations. The main conclusion is that the rapid-burst-like drug release can be hindered via the embedment of nanocarriers into biopolymeric matrices. The thermally stable formulation also holds the benefit of uniform active substance distribution after freeze-drying.

Automated summary

The current research aims to investigate the relationship between the formulation components and conditions in a binary drug delivery system. The development provides a simpler and scalable formulation process compared to chemical modifications of polymers with alginate. The results demonstrate that a multi-level factorial design-based approach ensures the development of a value-added polymeric micelle formulation with uniform size and monodisperse size distribution. The embedment of nanocarriers into biopolymeric matrices can hinder rapid-burst-like drug release.